10550sek
0,5 %
Date:2025-05-15Time:18:00:00Latest report:Q1-2025List:Mid CapTicker:BIOG B
Market Cap:10 673 msekEnterprise Value:9 423 msekNet Sales:1 419 msekEarnings:309,7 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:105,50
MA50:107,44
MA200:113,08
Price/MA200:-6,7 %
RSI (14):52,8
Price/MA50:-1,8 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.